Sylvia A. Chung
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.
Journal: International journal of molecular sciences
Published: September 21, 2023
Eliciting calcium transients with UV nanosecond laser stimulation in adult patient-derived glioblastoma brain cancer cellsin vitro.
Journal: Journal of neural engineering
Published: October 03, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.
Journal: International journal of cancer
Published: February 16, 2022
Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
Journal: Molecular cancer research : MCR
Published: September 16, 2019
A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype.
Journal: Cold Spring Harbor molecular case studies
Published: August 26, 2018
Combination of palbociclib and radiotherapy for glioblastoma.
Journal: Cell death discovery
Published: February 14, 2017
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
Journal: Gynecologic oncology
Published: February 27, 2015
Localization of bone morphogenetic protein 13 in human intervertebral disc and its molecular and functional effects in vitro in 3D culture.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Published: February 06, 2015
Dual-targeting of aberrant glucose metabolism in glioblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 11, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026